Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v3-EN
Language French English
Date Updated 2019-04-16 2019-01-29
Drug Identification Number 02449943 02449943
Brand name XIGDUO XIGDUO
Common or Proper name dapagliflozin and metformin hydrochloride tablets dapagliflozin and metformin hydrochloride tablets
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients METFORMIN HYDROCHLORIDE Dapagliflozin METFORMIN HYDROCHLORIDE Dapagliflozin
Strength(s) 1000MG 5MG 1000MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 6 x 10 (blister) 6 x 10 (blister)
ATC code A10BD A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-01-28 2019-01-28
Actual start date
Estimated end date 2019-02-04 2019-02-04
Actual end date 2019-04-12
Shortage status Resolved Actual shortage
Company comments
Health Canada comments